Botulinum neurotoxin: a marvel of protein design.
暂无分享,去创建一个
[1] H. Bigalke,et al. Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G* , 2004, Journal of Biological Chemistry.
[2] S. Swaminathan,et al. Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B. , 2001, Acta crystallographica. Section D, Biological crystallography.
[3] T. Tsuji,et al. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. , 2008, Microbial pathogenesis.
[4] HERBERT A. SIMON,et al. The Architecture of Complexity , 1991 .
[5] A T Brünger,et al. Structural Changes Are Associated with Soluble N-Ethylmaleimide-sensitive Fusion Protein Attachment Protein Receptor Complex Formation* , 1997, The Journal of Biological Chemistry.
[6] J. Vederas,et al. Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.
[7] H. Yanai,et al. Inhibitor‐assisted refolding of protease: A protease inhibitor as an intramolecular chaperone , 2005, FEBS letters.
[8] M. Bodeker,et al. Novel Chimeras of Botulinum Neurotoxins A and E Unveil Contributions from the Binding, Translocation, and Protease Domains to Their Functional Characteristics* , 2008, Journal of Biological Chemistry.
[9] R. Stevens,et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.
[10] S. Ovsepian,et al. Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive Potential , 2009, The Journal of Neuroscience.
[11] Leonard A. Smith,et al. Enzymatic Autocatalysis of Botulinum A Neurotoxin Light Chain , 2001, Journal of protein chemistry.
[12] A. Dickenson,et al. Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain , 2002, Movement disorders : official journal of the Movement Disorder Society.
[13] A. Finkelstein. Channels formed in phospholipid bilayer membranes by diphtheria, tetanus, botulinum and anthrax toxin. , 1990, Journal de physiologie.
[14] K. Janda,et al. Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. , 2006, Biochemistry.
[15] Junying Yuan,et al. The PHD Finger of the Chromatin-Associated Protein ING2 Functions as a Nuclear Phosphoinositide Receptor , 2003, Cell.
[16] K. Bostian,et al. Proteolysis of synthetic peptides by type A botulinum neurotoxin , 1995, Journal of protein chemistry.
[17] Giampietro Schiavo,et al. SNARE motif and neurotoxins , 1994, Nature.
[18] A. Brunger,et al. A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. , 2008, Structure.
[19] Axel T. Brunger,et al. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity , 2006, Nature.
[20] M. Rapport,et al. THE BINDING OF BOTULINUM TOXIN TO MEMBRANE LIPIDS: SPHINGOLIPIDS, STEROIDS AND FATTY ACIDS , 1971, Journal of neurochemistry.
[21] J. Ren,et al. Interaction of diphtheria toxin T domain with molten globule-like proteins and its implications for translocation. , 1999, Science.
[22] R. Stevens,et al. Sequence homology and structural analysis of the clostridial neurotoxins. , 1999, Journal of molecular biology.
[23] B. Davletov,et al. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves , 2006, FEBS letters.
[24] L. Simpson. Botulinum toxin and tetanus toxin recognize similar membrane determinants , 1984, Brain Research.
[25] M. Montal,et al. Crucial Role of the Disulfide Bridge between Botulinum Neurotoxin Light and Heavy Chains in Protease Translocation across Membranes* , 2007, Journal of Biological Chemistry.
[26] J. Alves,et al. Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization. , 2002, Biochemistry.
[27] A. E. Rossi,et al. RyR1 S-Nitrosylation Underlies Environmental Heat Stroke and Sudden Death in Y522S RyR1 Knockin Mice , 2008, Cell.
[28] L. Simpson,et al. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. , 1994, The Journal of pharmacology and experimental therapeutics.
[29] A. T. Brunger,et al. Identification of a minimal core of the synaptic SNARE complex sufficient for reversible assembly and disassembly. , 1998, Biochemistry.
[30] M. Montal,et al. Assembly of a Ternary Complex by the Predicted Minimal Coiled-coil-forming Domains of Syntaxin, SNAP-25, and Synaptobrevin , 1998, The Journal of Biological Chemistry.
[31] K. Takeuchi,et al. Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and Phospholipid , 2005, Journal of Biological Chemistry.
[32] K. Aktories,et al. Cellular uptake of Clostridium botulinum C2 toxin: membrane translocation of a fusion toxin requires unfolding of its dihydrofolate reductase domain. , 2003, Biochemistry.
[33] T. Südhof,et al. Complexin Controls the Force Transfer from SNARE Complexes to Membranes in Fusion , 2009, Science.
[34] R. Stevens,et al. Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction , 2008, PLoS pathogens.
[35] E. Neale,et al. The Role of the Synaptic Protein SNAP-25 in the Potency of Botulinum Neurotoxin Type A* , 2001, The Journal of Biological Chemistry.
[36] T. Südhof,et al. Membrane Fusion: Grappling with SNARE and SM Proteins , 2009, Science.
[37] J. Dolly,et al. Two Protein Trafficking Processes at Motor Nerve Endings Unveiled by Botulinum Neurotoxin E , 2007, Journal of Pharmacology and Experimental Therapeutics.
[38] R. Stevens,et al. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin , 2007, Nature Biotechnology.
[39] Chao Zhang,et al. The unfolded protein response signals through high-order assembly of Ire1 , 2009, Nature.
[40] S. Tosatto,et al. The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. , 2009, Biochemical and biophysical research communications.
[41] Silvio C. E. Tosatto,et al. Electric dipole reorientation in the interaction of botulinum neurotoxins with neuronal membranes , 2009, FEBS letters.
[42] D. Boger,et al. An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists , 2007, Proceedings of the National Academy of Sciences.
[43] A. Brunger,et al. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity. , 2007, Biochemistry.
[44] James J. Schmidt,et al. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. , 2005, Biochemistry.
[45] M. McComb,et al. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex , 2003, Journal of Cell Biology.
[46] G. Schiavo,et al. Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes. , 1989, The Biochemical journal.
[47] S. Swaminathan,et al. Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212-->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway. , 2004, Biochemistry.
[48] B. Rupp,et al. Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] L. Simpson. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. , 1980, The Journal of pharmacology and experimental therapeutics.
[50] L. Simpson,et al. Identification of the major steps in botulinum toxin action. , 2004, Annual review of pharmacology and toxicology.
[51] C. Schengrund,et al. Botulinum Neurotoxin A Activity Is Dependent upon the Presence of Specific Gangliosides in Neuroblastoma Cells Expressing Synaptotagmin I* , 2002, The Journal of Biological Chemistry.
[52] J. Marks,et al. Molecular Architecture of Botulinum Neurotoxin E Revealed by Single Particle Electron Microscopy* , 2008, Journal of Biological Chemistry.
[53] Kalle Gehring,et al. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains , 2008, Nature.
[54] Richa Rawat,et al. Substrate Binding Mode and Its Implication on Drug Design for Botulinum Neurotoxin A , 2008, PLoS pathogens.
[55] M. Montal,et al. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel , 2003, Nature Structural Biology.
[56] Yu-liangSHI,et al. Cure of experimental botulism and antibotulismic effect of toosendanin , 2004 .
[57] E. Yavin,et al. Tetanus toxin receptors on nerve cells contain a trypsin-sensitive component. , 1986, European journal of biochemistry.
[58] A. Omori,et al. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. , 1994, The Journal of biological chemistry.
[59] R. Stevens,et al. Structural basis of cell surface receptor recognition by botulinum neurotoxin B , 2006, Nature.
[60] U. Weller,et al. Cooperative action of the light chain of tetanus toxin and the heavy chain of botulinum toxin type A on the transmitter release of mammalian motor endplates , 1991, Neuroscience Letters.
[61] R. Stevens,et al. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition. , 2005, Biochemistry.
[62] J. Rothman,et al. Alternative Zippering as an On-Off Switch for SNARE-Mediated Fusion , 2009, Science.
[63] J. Barbieri,et al. Substrate Recognition of VAMP-2 by Botulinum Neurotoxin B and Tetanus Neurotoxin* , 2008, Journal of Biological Chemistry.
[64] J. Barbieri,et al. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. , 2009, Biochemistry.
[65] A. Brunger,et al. Single-molecule studies of the neuronal SNARE fusion machinery. , 2009, Annual review of biochemistry.
[66] Axel T Brunger,et al. Structure and function of SNARE and SNARE-interacting proteins , 2005, Quarterly Reviews of Biophysics.
[67] Helmut Grubmüller,et al. Molecular Anatomy of a Trafficking Organelle , 2006, Cell.
[68] E. Seto,et al. Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.
[69] R. Campbell,et al. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin , 2008, Nature.
[70] H. E. Marshall,et al. Protein S-nitrosylation: purview and parameters , 2005, Nature Reviews Molecular Cell Biology.
[71] Axel T. Brunger,et al. Substrate recognition strategy for botulinum neurotoxin serotype A , 2004, Nature.
[72] L. Simpson. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. , 1983, The Journal of pharmacology and experimental therapeutics.
[73] E. Neher,et al. Exocytotic mechanism studied by truncated and zero layer mutants of the C‐terminus of SNAP‐25 , 2000, The EMBO journal.
[74] Kazuki Sato,et al. The high‐affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a , 1996, FEBS letters.
[75] C. Montecucco,et al. Comparison of the pH-induced conformational change of different clostridial neurotoxins. , 2004, Biochemical and biophysical research communications.
[76] S. Clarke,et al. Protein arginine methylation in mammals: who, what, and why. , 2009, Molecular cell.
[77] A. Ferrer-Montiel,et al. Tyrosine Phosphorylation Modulates the Activity of Clostridial Neurotoxins* , 1996, The Journal of Biological Chemistry.
[78] G. Schiavo,et al. Functional characterisation of tetanus and botulinum neurotoxins binding domains. , 1999, Journal of cell science.
[79] D. Lacy,et al. Botulinum Neurotoxin Devoid of Receptor Binding Domain Translocates Active Protease , 2008, PLoS pathogens.
[80] B. Davletov,et al. Munc18-1 is critical for plasma membrane localization of syntaxin1 but not of SNAP-25 in PC12 cells. , 2007, Molecular biology of the cell.
[81] Thomas C. Südhof,et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 , 1993, Nature.
[82] F. Benfenati,et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin , 1992, Nature.
[83] S. Kozaki,et al. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex. , 2007, Microbial pathogenesis.
[84] S. Swaminathan,et al. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. , 2005, Biochemistry.
[85] Leonard A. Smith,et al. Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A , 2003, The Journal of Biological Chemistry.
[86] A. Brunger,et al. Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[87] T. Binz,et al. Cell entry strategy of clostridial neurotoxins , 2009, Journal of neurochemistry.
[88] R. Stevens,et al. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity. , 2006, Biochemistry.
[89] A. Chenal,et al. Membrane Interaction of Botulinum Neurotoxin A Translocation (T) Domain , 2008, Journal of Biological Chemistry.
[90] S. Swaminathan,et al. Structural analysis of the catalytic domain of tetanus neurotoxin. , 2005, Toxicon : official journal of the International Society on Toxinology.
[91] M. Inouye,et al. A Pathway for Conformational Diversity in Proteins Mediated by Intramolecular Chaperones* , 1999, The Journal of Biological Chemistry.
[92] J. Dolly,et al. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. , 1994, Biochemistry.
[93] W. Tepp,et al. Status of Cys Residues in the Covalent Structure of Botulinum Neurotoxin Types A, B, and E , 1998, Journal of protein chemistry.
[94] R. Benz,et al. Clostridium botulinum C2 Toxin , 2003, Journal of Biological Chemistry.
[95] T. Nishiki,et al. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. , 1998, Microbial pathogenesis.
[96] M. Sekiguchi,et al. Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA , 1996, Neuroscience Letters.
[97] Philip K. Russell,et al. Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.
[98] V. Sathyamoorthy,et al. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E. , 1985, The Journal of biological chemistry.
[99] Alfred G Tamayo,et al. COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro , 2008, Proceedings of the National Academy of Sciences.
[100] M. Simon,et al. Insertion of diphtheria toxin into and across membranes: role of phosphoinositide asymmetry , 1982, Nature.
[101] R. K. Gordon,et al. TCEP treatment reduces proteolytic activity of BoNT/B in human neuronal SHSY‐5Y cells , 2009, Journal of cellular biochemistry.
[102] C. Montecucco. How do tetanus and botulinum toxins bind to neuronal membranes , 1986 .
[103] J. Keller,et al. Uptake of botulinum neurotoxin into cultured neurons. , 2004, Biochemistry.
[104] L. Li,et al. Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain. , 2000, Biochemistry.
[105] Raymond C Stevens,et al. Retraction: Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 Å resolution , 2009, Nature Structural &Molecular Biology.
[106] J. Canaves,et al. The 26‐mer peptide released from SNAP‐25 cleavage by botulinum neurotoxin E inhibits vesicle docking , 1998, FEBS letters.
[107] R. Stafford,et al. Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1′ binding subsite , 1998, FEBS letters.
[108] J. Barbieri,et al. Mechanism of Substrate Recognition by Botulinum Neurotoxin Serotype A* , 2007, Journal of Biological Chemistry.
[109] Leonard A. Smith,et al. Identification and Biochemical Characterization of Small-Molecule Inhibitors of Clostridium botulinum Neurotoxin Serotype A , 2009, Antimicrobial Agents and Chemotherapy.
[110] B. Davletov,et al. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E , 2004, EMBO reports.
[111] J. Barbieri,et al. Multiple Pocket Recognition of SNAP25 by Botulinum Neurotoxin Serotype E* , 2007, Journal of Biological Chemistry.
[112] Eric A. Johnson,et al. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells , 2003, The Journal of cell biology.
[113] H. Dyson,et al. Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.
[114] M. Montal,et al. Characterization ofClostridial botulinum neurotoxin channels in neuroblastoma cells , 2006, Neurotoxicity Research.
[115] R. Collier,et al. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient. , 2006, Journal of molecular biology.
[116] Kim D Janda,et al. Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility. , 2007, Chemistry & biology.
[117] K. Janda,et al. Bimodal modulation of the botulinum neurotoxin protein-conducting channel , 2009, Proceedings of the National Academy of Sciences.
[118] Richard I. Morimoto,et al. Adapting Proteostasis for Disease Intervention , 2008, Science.
[119] J. Barbieri,et al. Engineering botulinum neurotoxin to extend therapeutic intervention , 2009, Proceedings of the National Academy of Sciences.
[120] Tobin J Dickerson,et al. The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication. , 2006, ACS chemical biology.
[121] Leonard A. Smith,et al. N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B. , 2005, Biochemical and biophysical research communications.
[122] A. Brünger,et al. A Structural Change Occurs upon Binding of Syntaxin to SNAP-25* , 1997, The Journal of Biological Chemistry.
[123] T. Weil,et al. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept , 2007, Proceedings of the National Academy of Sciences.
[124] C. Montecucco,et al. Presynaptic neurotoxins with enzymatic activities. , 2008, Handbook of experimental pharmacology.
[125] Benedikt Westermann,et al. SNAREpins: Minimal Machinery for Membrane Fusion , 1998, Cell.
[126] G. Ahnert-Hilger,et al. Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates , 2004, Journal of neurochemistry.
[127] Harald Stenmark,et al. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins , 2009, Nature.
[128] T. Südhof,et al. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. , 1994, The EMBO journal.
[129] L. O. Ticknor,et al. Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial Strains , 2006, Journal of bacteriology.
[130] M. Montal,et al. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes , 2007, Proceedings of the National Academy of Sciences.
[131] S. Swaminathan,et al. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B , 2000, Nature Structural Biology.
[132] S. Swaminathan,et al. Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F , 2009, Nature Structural &Molecular Biology.
[133] C. Quinn,et al. Inhibition of Vesicular Secretion in Both Neuronal and Nonneuronal Cells by a Retargeted Endopeptidase Derivative ofClostridium botulinum Neurotoxin Type A , 2000, Infection and Immunity.
[134] Dirk Tiemann,et al. The Host Cell Chaperone Hsp90 Is Essential for Translocation of the Binary Clostridium botulinum C2 Toxin into the Cytosol* , 2003, Journal of Biological Chemistry.
[135] Karen N. Allen,et al. Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex. , 2008, Biochemistry.
[136] R. S. Williams,et al. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. , 1986, European journal of biochemistry.
[137] Eric A. Johnson,et al. SV2 Is the Protein Receptor for Botulinum Neurotoxin A , 2006, Science.
[138] Marcus Mueller,et al. The structure of a cytolytic α-helical toxin pore reveals its assembly mechanism , 2009, Nature.
[139] Edwin R Chapman,et al. How does synaptotagmin trigger neurotransmitter release? , 2008, Annual review of biochemistry.
[140] R. Barbano. BOTULINUM TOXIN: THERAPEUTIC CLINICAL PRACTICE & SCIENCE , 2010, Neurology.
[141] S. Collins,et al. Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum , 2009, Science.
[142] Helen Ho,et al. Plasma membrane localization signals in the light chain of botulinum neurotoxin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[143] Raymond C. Stevens,et al. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 Å resolution , 2000, Nature Structural Biology.
[144] S. Nauenburg,et al. Proteolysis of SNAP‐25 Isoforms by Botulinum Neurotoxin Types A, C, and E , 1999, Journal of neurochemistry.
[145] Reinhard Jahn,et al. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution , 1998, Nature.
[146] R. Stevens,et al. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. , 2006, Journal of molecular biology.
[147] Colin Rickman,et al. High Affinity Interaction of Syntaxin and SNAP-25 on the Plasma Membrane Is Abolished by Botulinum Toxin E* , 2004, Journal of Biological Chemistry.
[148] K. Acharya,et al. Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A. , 2009, Biochemical and biophysical research communications.
[149] H. Bigalke,et al. The HCC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction , 2003, Molecular microbiology.
[150] Edwin R Chapman,et al. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. , 2008, Molecular biology of the cell.
[151] Reinhard Jahn,et al. Helical extension of the neuronal SNARE complex into the membrane , 2009, Nature.
[152] P. Alexander,et al. Catalysis of a protein folding reaction: mechanistic implications of the 2.0 A structure of the subtilisin-prodomain complex. , 1995, Biochemistry.
[153] Axel T Brunger,et al. 2.3 A crystal structure of tetanus neurotoxin light chain. , 2005, Biochemistry.
[154] D. Toomre,et al. A Phosphoinositide Switch Controls the Maturation and Signaling Properties of APPL Endosomes , 2009, Cell.
[155] L. Tauc,et al. A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly. , 1993, The Journal of biological chemistry.
[156] R. Collier,et al. Evidence for a Proton–Protein Symport Mechanism in the Anthrax Toxin Channel , 2009, The Journal of general physiology.
[157] Axel T Brunger,et al. Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain , 2007, PLoS pathogens.
[158] J. Navaza,et al. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. , 2008, Journal of molecular biology.